Júlia Folguera-Profitós

Júlia Folguera-Profitós

Auto-generated profile, based on publicly available information

Júlia Folguera-Profitós

Catalan Health Service, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JPJordi Piera-Jiménez
Jordi Piera-Jiménez
GCGerard Carot-Sans
Gerard Carot-Sans
MRMarina Ramiro-Pareta
Marina Ramiro-Pareta
MNMaria Mercedes Nogueras
Maria Mercedes Nogueras
JFJúlia Folguera-Profitós
Júlia Folguera-Profitós
PPPol Pérez-Sust
Pol Pérez-Sust
Over the past decades, health care systems have significantly evolved due to aging populations, chronic diseases, and higher-quality care expectations. Concurrently with the added health care needs, information and communications technology advancements have transformed health care delivery. Technologies such as telemedicine, electronic health records, and mobile health apps promise enhanced accessibility, efficiency, and patient outcomes, leading to more personalized, data-driven care. However, organizational, political, and cultural barriers and the fragmented approach to health information management are challenging the integration of these technologies to effectively support health care delivery. This fragmentation collides with the need for integrated care pathways that focus on holistic health and wellness. Catalonia (northeast Spain), a region of 8 million people with universal health care coverage and a single public health insurer but highly heterogeneous health care service providers, has experienced outstanding digitalization and integration of health information over the past 25 years, when the first transition from paper to digital support occurred. This Viewpoint describes the implementation of health ITs at a system level, discusses the hits and misses encountered in this journey, and frames this regional implementation within the global context. We present the architectures and use trends of the health information platforms over time. This provides insightful information that can be used by other systems worldwide in the never-ending transformation of health care structure and services.

30 June 2023 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
DVDamià Valero-Bover
Damià Valero-Bover
DMDavid Monterde
David Monterde
GCGerard Carot-Sans
Gerard Carot-Sans
MCMiguel Cainzos-Achirica
Miguel Cainzos-Achirica
JCJosep Comín-Colet
Josep Comín-Colet
JPJordi Piera-Jiménez
Jordi Piera-Jiménez
Purpose: To assess the contribution of age and comorbidity to the risk of critical illness in hospitalized COVID-19 patients using increasingly exhaustive tools for measuring comorbidity burden. Patients and Methods: We assessed the effect of age and comorbidity burden in a retrospective, multicenter cohort of patients hospitalized due to COVID-19 in Catalonia (North-East Spain) between March 1, 2020, and January 31, 2022. Vaccinated individuals and those admitted within the first of the six COVID-19 epidemic waves were excluded from the primary analysis but were included in secondary analyses. The primary outcome was critical illness, defined as the need for invasive mechanical ventilation, transfer to the intensive care unit (ICU), or in-hospital death. Explanatory variables included age, sex, and four summary measures of comorbidity burden on admission extracted from three indices: the Charlson index (17 diagnostic group codes), the Elixhauser index and count (31 diagnostic group codes), and the Queralt DxS index (3145 diagnostic group codes). All models were adjusted by wave and center. The proportion of the effect of age attributable to comorbidity burden was assessed using a causal mediation analysis. Results: The primary analysis included 10,551 hospitalizations due to COVID-19; of them, 3632 (34.4%) experienced critical illness. The frequency of critical illness increased with age and comorbidity burden on admission, irrespective of the measure used. In multivariate analyses, the effect size of age decreased with the number of diagnoses considered to estimate comorbidity burden. When adjusting for the Queralt DxS index, age showed a minimal contribution to critical illness; according to the causal mediation analysis, comorbidity burden on admission explained the 98.2% (95% CI 84.1– 117.1%) of the observed effect of age on critical illness. Conclusion: Comorbidity burden (when measured exhaustively) explains better than chronological age the increased risk of critical illness observed in patients hospitalized with COVID-19.

12 July 2026 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
BTBlanca Torres‐Cardús
Blanca Torres‐Cardús
EVEmili Vela
Emili Vela
DMDavid Monterde
David Monterde
GCGerard Carot‐Sans
Gerard Carot‐Sans
JPJordi Piera-Jiménez
Jordi Piera-Jiménez
JCJosep Comín-Colet
Josep Comín-Colet
Aim: Old age is associated with poor outcomes in patients with heart failure (HF). This study aimed to assess the impact of age on the effectiveness of a new integrated, transition‐based nurse‐led HF programme in a healthcare area with 209,255 inhabitants. Methods: We conducted a population‐based evaluation of all patients discharged from the hospital with International Classification of Diseases, ninth revision, Clinical Modification code for HF as the primary diagnosis in Catalonia between 2015 and 2019. We compared outcomes between patients exposed to the new HF programme with the rest of Catalonia, stratified by age. Results: A total of 77,554 patients with HF were classified into three groups: 15–74, 75–84 and >84 years. In the Bellvitge University Hospital (HUB)‐Delta area (3396 HF patients), comparison of the pre‐implementation and consolidation periods of the programme showed a decrease in clinically related hospitalisation in the youngest group (hazard ratio [HR] 0.87; confidence interval [CI] 0.84–0.91, p  < 0.001), the middle‐age group (HR 0.90; CI 0.87–0.93, p < 0.001) and the oldest group (HR 0.83; CI 0.83–0.89; p  < 0.001). Similar results were observed for all‐cause mortality and readmission. Compared with HF care in the rest of Catalonia, the new programme resulted in a significant reduction in all‐cause mortality across all age groups and all‐cause hospitalisations among the young and middle‐aged groups during the programme's transition and consolidation periods. Conclusions: Implementation of the new HF programme within a universal‐coverage healthcare system was associated with significant reductions in all‐cause clinically related hospitalisations and HF readmissions across all age groups.

29 July 2025 in JMIR Preprints
Verified
Preprint
Open access
JFJúlia Folguera-Profitós
Júlia Folguera-Profitós
MRMarina Ramiro-Pareta
Marina Ramiro-Pareta
GCGerard Carot-Sans
Gerard Carot-Sans
AJAlba Jiménez-Rueda
Alba Jiménez-Rueda
JAJúlia Aznar-Roig
Júlia Aznar-Roig
JPJordi Piera-Jiménez
Jordi Piera-Jiménez
BACKGROUND The use of artificial intelligence (AI) to generate synthetic images has been increasingly used to overcome the scarcity of large, regulatory-compliant medical images datasets. However, their quality and actual utility in algorithm development across deep learning architectures, medical settings, and image type has been poorly assessed. OBJECTIVE To revise the use of synthetic images for algorithm development and assess their quality and effect on downstream algorithms trained with these images, according to AI architecture, medical setting, and image type. METHODS We conducted a systematic review following PRISMA guidelines. PubMed was searched in January 2024 using terms related to synthetic image generation, diagnostic imaging, and model evaluation, restricted to January 2020-December 2023. Eligible studies evaluated diagnostic, or follow-up applications incorporating synthetic images, reported quantitative measures of image quality or model performance, used human imaging data, and were published as full-text English articles. Studies using synthetic images for non-diagnostic purposes, microscopic/histopathology imaging, and non-primary literature were excluded. Two independent reviewers conducted study selection with discrepancies resolved through group discussion. Data extraction focused on generative architectures, image quality metrics (fidelity, perceptual, Turing-style, distribution-alignment), and downstream model performance outcomes. Risk of bias was assessed using custom criteria based on reporting guidelines for observational studies. Due to insufficient variance reporting across studies, only descriptive analyses (and not pooled analyses) were conducted. RESULTS From 952 articles identified, 94 studies met inclusion criteria. MRI, X-ray, and CT were the predominant imaging modalities (representing the majority of studies), primarily applied in oncology, respiratory diseases, and neurology. GAN-based architectures dominated synthetic image generation (83% of studies). Among 49 distinct quality metrics identified, Turing-style realism metrics were most frequently used, followed by perceptual and fidelity metrics. Seventy-six studies evaluated downstream model performance, revealing that training exclusively on synthetic images often resulted in performance decrements, particularly for segmentation tasks (declining Dice scores). In contrast, augmenting original datasets with synthetic images showed more consistent improvements, especially for classification metrics across most imaging modalities. Risk of bias assessment revealed significant methodological concerns, with only 22% of studies rated as low risk; primary sources of bias included inadequate reporting of sampling strategies, population characteristics, and lack of measures of variance/confidence. CONCLUSIONS Synthetic images show promise for addressing dataset limitations in medical AI, but current evidence demonstrates substantial methodological heterogeneity and modest performance improvements that limit clinical translation. The field urgently requires standardized evaluation frameworks and consensus reporting guidelines. Future research should prioritize developing robust, clinically validated frameworks to guide responsible deployment of synthetic image-enhanced AI systems in healthcare. CLINICALTRIAL PROSPERO (CRD42023369125).

15 October 2026 in JMIR AI
Verified
Journal Article
Open access
JFJúlia Folguera-Profitós
Júlia Folguera-Profitós
MRMarina Ramiro-Pareta
Marina Ramiro-Pareta
GCGerard Carot-Sans
Gerard Carot-Sans
AJAlba Jiménez-Rueda
Alba Jiménez-Rueda
JAJúlia Aznar-Roig
Júlia Aznar-Roig
JPJordi Piera-Jiménez
Jordi Piera-Jiménez
Background: AI has increasingly been used to generate synthetic images to overcome the scarcity of large, regulatory-compliant medical image datasets. However, their quality and actual utility for algorithm development across deep learning architectures, medical settings, and image types have been poorly assessed. Objective: This study aimed to review the use of synthetic images for algorithm development and to assess their quality and effects on downstream algorithms trained on these images, according to AI architecture, medical setting, and image type. Methods: The authors conducted a systematic review of studies published between January 2020 and September 2025. PubMed, Scopus, IEEE Xplore, and Embase were searched for peer-reviewed studies evaluating synthetic images generated from human medical imaging data. Data were extracted for imaging modalities, generative architectures, image-quality assessment methods, downstream model performance, explainability approaches, reproducibility practices, and risk of bias. Given substantial heterogeneity and incomplete statistical reporting, findings were synthesized descriptively. Results: A total of 160 studies were included. Generative adversarial network–based architectures dominated image generation (119 studies, 74.4%), although hybrid and diffusion-based approaches became increasingly represented in recent years. Image-quality evaluation was highly heterogeneous: 50 studies included human-reader evidence, and 101 reported an automated image-quality assessment. Synthetic-only training generally underperformed real-data training, including a median Dice similarity coefficient change of –10.2% for segmentation. Adding synthetic data to real training sets was associated with median improvements in classification precision (+7.8%), recall (+5.3%), F 1 -score (+5.5%), accuracy (+4.3%), and area under the curve (+4.0%), while the median Dice coefficient improvement was +1.2%. Explainability evidence was reported in 68 (42.5%) studies and was rarely validated against expert annotations. Reproducibility reporting was inconsistent, and only 38% (60/160) of studies were judged to have low overall risk of bias. Conclusions: Unlike previous reviews restricted to particular diseases, imaging modalities, or generative architectures, this review provides a cross-domain quantitative synthesis of both synthetic-image quality assessment and downstream model performance. Synthetic images currently appear more valuable as a complement to real training data than as a replacement, with modest improvements in classification performance, smaller gains in segmentation, and generally poorer performance with synthetic-only training. For researchers, developers, and regulators, these findings highlight the need for standardized multimethod image-quality evaluation, complete reporting, and rigorous external validation before synthetic-image pipelines are translated into clinical AI applications.